These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5861160)

  • 1. [Experimental tests of antitetanus immunization with anatoxic products derived from extracts and entire bodies of tetanus bacilli].
    D'Antona D
    Nuovi Ann Ig Microbiol; 1965; 16(3):193-206. PubMed ID: 5861160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental trials of tetanus immunization with toxoids obtained from extracts and integral bodies of tetanus bacilli].
    D'Antona D
    Rev Immunol Ther Antimicrob; 1965; 29(3):95-116. PubMed ID: 5842856
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental study upon the efficacy of some accelerated vaccination schedules in tetanus prophylaxis.
    Dimache G; Croitoru M; Durbaca S; Stoean C; Dimache A
    Roum Arch Microbiol Immunol; 1993; 52(4):247-54. PubMed ID: 7827361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to a single tetanus toxoid booster in young women in rural south India.
    Aruldas K; Muliyil JP; Mathai E; Abraham S; Joseph A; Inbamalar U; Aruldas V
    Natl Med J India; 2001; 14(1):22-3. PubMed ID: 11242693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effective toxoid from tetanus toxin prepared by stepwise iodination of purified toxin.
    Soares HR; Nunes RL; Prado SM; Higashi HG; Heneine IF
    Biologicals; 1994 Mar; 22(1):29-33. PubMed ID: 8068311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and immunogenic studies on purified tetanus toxoid.
    Nielsen PA; Ablondi FB; Querry MV; Gussoni C; Cooper MS
    J Immunol; 1967 Jun; 98(6):1248-56. PubMed ID: 4961126
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sensitizing properties of tetanus toxoid fractions separated by ion-exchange chromatography].
    Neprina GS; Medunitsyn NV; Golshmid VK
    Biull Eksp Biol Med; 1972 Aug; 73(8):70-3. PubMed ID: 4635289
    [No Abstract]   [Full Text] [Related]  

  • 9. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
    Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitetanus prophylaxis.
    N Engl J Med; 1984 Feb; 310(7):466-7. PubMed ID: 6694691
    [No Abstract]   [Full Text] [Related]  

  • 11. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosol immunization of guinea pigs with fluid tetanus toxoid.
    Yamashiroya HM; Ehrlich R; Magis JM
    J Bacteriol; 1966 Feb; 91(2):903-4. PubMed ID: 5894236
    [No Abstract]   [Full Text] [Related]  

  • 13. Liposomes as immunological adjuvants for tetanus vaccine.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):263-9. PubMed ID: 11845438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tetanus toxoid administered by intradermal route in association with typhoid vaccine.
    Dimache G; Croitoru M; Ciordaş C; Stoean C; Durbacă S; Macovei A; Bălută MM
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):61-9. PubMed ID: 6529361
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the study of the degradation of biological products. V. Influence of the initial immunogenicity on the degradation with time of natural tetanus anatoxin].
    Demian L; Lazăr M; Laşco N; Kranzdorf H; Freund S
    Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):451-8. PubMed ID: 5877483
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guidelines for the use of antitetanus vaccination].
    Ribero ML; Volpato C
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):550-3. PubMed ID: 7248089
    [No Abstract]   [Full Text] [Related]  

  • 17. Residual antitetanus protection 17 to 19 years after active immunization.
    WORMAN RK; KISS Z; CAMP FA; McDONALD KE; SCHENK WG
    Surg Gynecol Obstet; 1963 May; 116():576-8. PubMed ID: 14001885
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetanus toxoid-loaded transfersomes for topical immunization.
    Gupta PN; Mishra V; Singh P; Rawat A; Dubey P; Mahor S; Vyas SP
    J Pharm Pharmacol; 2005 Mar; 57(3):295-301. PubMed ID: 15807984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Artificial antitetanus immunity. I. Curve of antibody formation in the guinea pig].
    RUGIERO HR; MANZULLO A; CHAROSKY L; BENTOLILA M; PENNINPEDE FC; FERRARIO JC
    Rev Asoc Med Argent; 1963 Mar; 77():112-5. PubMed ID: 13983244
    [No Abstract]   [Full Text] [Related]  

  • 20. A human monoclonal antibody specific for tetanus toxoid.
    Olsson L; Mazauric T; Vincent-Falquet JC; Armand J
    Dev Biol Stand; 1984; 57():87-91. PubMed ID: 6526153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.